Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-26-201758
Filing Date
2026-05-01
Accepted
2026-05-01 17:31:07
Documents
19

Document Format Files

Seq Description Document Type Size
1 424B4 d73463d424b4.htm 424B4 2338455
2 GRAPHIC g73463g00a03.jpg GRAPHIC 40157
3 GRAPHIC g73463g00n44.jpg GRAPHIC 210616
4 GRAPHIC g73463g01f03.jpg GRAPHIC 213822
5 GRAPHIC g73463g01f04.jpg GRAPHIC 131877
6 GRAPHIC g73463g01f05.jpg GRAPHIC 69098
7 GRAPHIC g73463g01f06.jpg GRAPHIC 63153
8 GRAPHIC g73463g01f07.jpg GRAPHIC 104952
9 GRAPHIC g73463g01f08.jpg GRAPHIC 103851
10 GRAPHIC g73463g01k38.jpg GRAPHIC 114114
11 GRAPHIC g73463g01n38.jpg GRAPHIC 153068
12 GRAPHIC g73463g01n39.jpg GRAPHIC 143900
13 GRAPHIC g73463g02n39.jpg GRAPHIC 100304
14 GRAPHIC g73463g04c52.jpg GRAPHIC 168363
15 GRAPHIC g73463g13a34.jpg GRAPHIC 125997
16 GRAPHIC g73463g14k41.jpg GRAPHIC 164266
17 GRAPHIC g73463g14k43.jpg GRAPHIC 134164
18 GRAPHIC g73463g32a32.jpg GRAPHIC 118064
19 GRAPHIC g73463g48a48.jpg GRAPHIC 113658
  Complete submission text file 0001193125-26-201758.txt   5246610
Mailing Address 6 TIDE STREET SUITE 400 BOSTON MA 02110
Business Address 6 TIDE STREET SUITE 400 BOSTON MA 02110 617-807-4062
Seaport Therapeutics, Inc. (Filer) CIK: 0002042347 (see all company filings)

EIN.: 992235719 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-294976 | Film No.: 26933946
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)